Levi L. Blazer

1.6k total citations
38 papers, 1.1k citations indexed

About

Levi L. Blazer is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Cellular and Molecular Neuroscience. According to data from OpenAlex, Levi L. Blazer has authored 38 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 7 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Levi L. Blazer's work include Protein Kinase Regulation and GTPase Signaling (9 papers), Receptor Mechanisms and Signaling (9 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Levi L. Blazer is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (9 papers), Receptor Mechanisms and Signaling (9 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Levi L. Blazer collaborates with scholars based in United States, Canada and United Kingdom. Levi L. Blazer's co-authors include Richard R. Neubig, Stephen M. Husbands, David L. Roman, Jarrett Adams, Sachdev S. Sidhu, Benita Sjögren, Stéphane Angers, C.H. Arrowsmith, Masoud Vedadi and Emma M. Turner and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Journal of Molecular Biology.

In The Last Decade

Levi L. Blazer

37 papers receiving 1.1k citations

Peers

Levi L. Blazer

CMN

ONCOL

CTM

RNMI

Jacky Chi Ki Ngo Hong Kong

Galia Maik-Rachline Israel

Martin Augustin Germany

Magdalena M. Szewczyk Canada

Paul S. Carter United Kingdom

Boaz Inbal Israel

Carol B. Fowler United States

Mathieu Lavallée‐Adam Canada

Chris R. Evelyn United States

Joseph F. Johnston United States

Jacky Chi Ki Ngo Hong Kong

Levi L. Blazer

893 ×1.0

109 ×0.9

CMN

81 ×0.9

ONCOL

39 ×0.5

CTM

66 ×0.9

RNMI

Citations per year, relative to Levi L. Blazer Levi L. Blazer (= 1×) peers Jacky Chi Ki Ngo

Countries citing papers authored by Levi L. Blazer

Since Specialization

Citations

This map shows the geographic impact of Levi L. Blazer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Levi L. Blazer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Levi L. Blazer more than expected).

Fields of papers citing papers by Levi L. Blazer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Levi L. Blazer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Levi L. Blazer. The network helps show where Levi L. Blazer may publish in the future.

Co-authorship network of co-authors of Levi L. Blazer

This figure shows the co-authorship network connecting the top 25 collaborators of Levi L. Blazer. A scholar is included among the top collaborators of Levi L. Blazer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Levi L. Blazer. Levi L. Blazer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Adams, Jarrett, Levi L. Blazer, Jacky Chung, et al.. (2025). An asymmetric tetrabody is a potent and efficacious agonist of the erythropoietin receptor in vitro and in vivo. Protein Science. 34(10). e70292–e70292.

Geraldo, Luiz Henrique, Yunling Xu, Levi L. Blazer, et al.. (2024). Monoclonal antibodies that block Roundabout 1 and 2 signaling target pathological ocular neovascularization through myeloid cells. Science Translational Medicine. 16(774). eadn8388–eadn8388. 2 indexed citations

Yang, Andy, Rony Chidiac, Hendrik W. Steenland, et al.. (2024). Exploiting spatiotemporal regulation of FZD5 during neural patterning for efficient ventral midbrain specification. Development. 151(5). 6 indexed citations

Griffiths, Samuel C., Jia Tan, Armin Wagner, et al.. (2024). Structure and function of the ROR2 cysteine-rich domain in vertebrate noncanonical WNT5A signaling. eLife. 13. 4 indexed citations

Singer, A.U., Levi L. Blazer, Lynda Ploder, et al.. (2024). Antigen‐binding fragments with improved crystal lattice packing and enhanced conformational flexibility at the elbow region as crystallization chaperones. Protein Science. 33(7). e5081–e5081. 1 indexed citations

Nabhan, Ahmad N., Joshua D. Webster, Jarrett Adams, et al.. (2023). Targeted alveolar regeneration with Frizzled-specific agonists. Cell. 186(14). 2995–3012.e15. 43 indexed citations

Liu, Silvia, Minakshi Poddar, Sucha Singh, et al.. (2022). Single-cell spatial transcriptomics reveals a dynamic control of metabolic zonation and liver regeneration by endothelial cell Wnt2 and Wnt9b. Cell Reports Medicine. 3(10). 100754–100754. 63 indexed citations

Gallo, Eugenio, Mingjun Zhang, Naiyu Wang, et al.. (2021). Inhibition of Cancer Cell Adhesion, Migration and Proliferation by a Bispecific Antibody that Targets two Distinct Epitopes on αv Integrins. Journal of Molecular Biology. 433(15). 167090–167090. 4 indexed citations

Tao, Yuyong, Monika Mis, Levi L. Blazer, et al.. (2019). Tailored tetravalent antibodies potently and specifically activate Wnt/Frizzled pathways in cells, organoids and mice. eLife. 8. 67 indexed citations

10.

Newsted, Daniel, Kathleen Watt, Sarah Nersesian, et al.. (2018). Blockade of TGF-β signaling with novel synthetic antibodies limits immune exclusion and improves chemotherapy response in metastatic ovarian cancer models. OncoImmunology. 8(2). e1539613–e1539613. 36 indexed citations

11.

Pavlovic, Zvezdan, Jarrett Adams, Levi L. Blazer, et al.. (2018). A synthetic anti-Frizzled antibody engineered for broadened specificity exhibits enhanced anti-tumor properties. mAbs. 10(8). 1157–1167. 55 indexed citations

12.

Blazer, Levi L., Evelyne Lima‐Fernandes, Elisa Gibson, et al.. (2016). PR Domain-containing Protein 7 (PRDM7) Is a Histone 3 Lysine 4 Trimethyltransferase. Journal of Biological Chemistry. 291(26). 13509–13519. 22 indexed citations

13.

Storaska, Andrew J., Meng Wu, Min Li, et al.. (2013). Reversible inhibitors of regulators of G-protein signaling identified in a high-throughput cell-based calcium signaling assay. Cellular Signalling. 25(12). 2848–2855. 22 indexed citations

14.

Sjögren, Benita, Levi L. Blazer, & Richard R. Neubig. (2010). Regulators of G Protein Signaling Proteins as Targets for Drug Discovery. Progress in molecular biology and translational science. 91. 81–119. 80 indexed citations

15.

Blazer, Levi L., David L. Roman, Alfred Chung, et al.. (2010). Reversible, Allosteric Small-Molecule Inhibitors of Regulator of G Protein Signaling Proteins. Molecular Pharmacology. 78(3). 524–533. 70 indexed citations

16.

Roman, David L., et al.. (2010). Allosteric Inhibition of the Regulator of G Protein Signaling–Gα Protein–Protein Interaction by CCG-4986. Molecular Pharmacology. 78(3). 360–365. 38 indexed citations

17.

Roof, Rebecca A., David L. Roman, Katarzyna Sobczyk‐Kojiro, et al.. (2009). A covalent peptide inhibitor of RGS4 identified in a focused one-bead, one compound library screen. BMC Pharmacology. 9(1). 9–9. 18 indexed citations

18.

Blazer, Levi L. & Richard R. Neubig. (2008). Small Molecule Protein–Protein Interaction Inhibitors as CNS Therapeutic Agents: Current Progress and Future Hurdles. Neuropsychopharmacology. 34(1). 126–141. 153 indexed citations

19.

Blazer, Levi L. & Michael D.P. Boyle. (2006). Use of protein chip mass spectrometry to monitor biotinylation reactions. Applied Microbiology and Biotechnology. 74(3). 717–722. 2 indexed citations

20.

Posada, Maria M., et al.. (2006). The Role of the VPS4A-Exosome Pathway in the Intrinsic Egress Route of a DNA-Binding Anticancer Drug. Pharmaceutical Research. 23(8). 1687–1695. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact